ASCL1 and neoplasm: We then analyzed single-cell RNA-seq data from 2 paired human SCLCs before and after cisplatin recurrence where a subpopulation of ASCL1/INSM1-low, inflammatory-high tumor cells emerged after cisplatin recurrence37.